GEN20 小时
Making Strides Toward Off-the-Shelf CAR T Cell Therapy for Cancer
A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.
来自MSN2 天
Research Paves Way for Off-the-Shelf CAR T Cells for Cancer Treatment
CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...
CARsgen's Allogeneic CD38 CAR-T Therapy Administers First Dose in an Investigator-Initiated ...
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the ...
Targeted Oncology11 天
First Dose of CD38-Targeting CAR T-Cell Therapy Administered in AML
The first patient with relapsed/refractory acute myeloid leukemia has received KJ-C2320, an allogeneic CAR T-cell therapy ...
Health Rounds: Old anti-inflammatory may delay colon cancer recurrence
Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...
VectorBuilder Powers FDA IND Approval of World’s First Umbilical Cord Blood-Derived ...
VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy ...
technologynetworks3 天
Study Paves Way for Off-the-Shelf Cancer CAR T-Cell Therapy
The research identifies a way to modify the donor CAR T cells, called allogeneic CAR T cells, so that they won’t be rejected by the patient receiving them and will persist in fighting the cancer. The ...
FiercePharma12 天
Atara's Ebvallo and pipeline candidate put on clinical hold in US after partner's failed ...
After receiving a complete response letter last week, the other shoe has dropped for Atara Biotherapeutics and its pipeline ...